2024 McDonald Criteria for Multiple Sclerosis Diagnosis
The 2024 McDonald criteria represent a major advancement in MS diagnosis by incorporating the optic nerve as a fifth anatomical location, allowing diagnosis with lesions in at least four of five locations without additional evidence, and introducing highly specific MRI biomarkers (central vein sign and paramagnetic rim lesions) plus CSF kappa free light chains as supportive diagnostic tools. 1, 2
Core Diagnostic Framework
Dissemination in Space (DIS) - Five Anatomical Locations
The 2024 criteria now recognize five anatomical locations for establishing DIS 1:
- Periventricular
- Juxtacortical or cortical
- Infratentorial
- Spinal cord
- Optic nerve (newly added)
Diagnostic Algorithm Based on Lesion Distribution
When lesions are present in ≥4 of 5 anatomical locations: MS can be diagnosed immediately without requiring dissemination in time (DIT), CSF analysis, or additional evidence 1
When lesions are present in <4 anatomical locations: Additional evidence is required based on the number of locations involved 1:
- Dissemination in time (DIT): Demonstrated by simultaneous enhancing and non-enhancing lesions on a single scan, OR new T2/FLAIR lesions on follow-up MRI
- Highly specific MRI markers: Central vein sign (CVS) or paramagnetic rim lesions (PRL)
- CSF findings: Oligoclonal bands or elevated kappa free light chains
- The specific combination required depends on how many anatomical locations show lesions (see table 1 in the guidelines)
Key Innovations in the 2024 Criteria
Optic Nerve Inclusion
The optic nerve is now the fifth anatomical location, addressing the previous exclusion despite optic neuritis being a frequent presenting symptom 1. Optic nerve involvement can be demonstrated through:
- MRI with fat-saturated sequences for detecting symptomatic optic nerve lesions 1
- Visual evoked potentials (VEP) - identified optic nerve lesions in 89% of cases in real-world application 3
- Optical coherence tomography 1
In practical application, VEP has proven highly effective for identifying optic nerve involvement when advanced MRI techniques are unavailable 3.
Novel High-Specificity MRI Biomarkers
Central Vein Sign (CVS) and Paramagnetic Rim Lesions (PRL) can now substitute for other diagnostic requirements when conventional imaging is insufficient 1. These markers require:
- Susceptibility-sensitive imaging sequences (now recommended for routine diagnostic use) 1
- Specialized radiologist training for confident interpretation 1
Important caveat: These advanced imaging markers are not yet widely available globally and should be reserved for diagnostically uncertain cases where conventional MRI and other methods cannot establish the diagnosis 4.
Radiologically Isolated Syndrome (RIS)
RIS can now be classified as MS when specific conditions are met, allowing diagnosis in individuals without symptoms but with incidental MS-suggestive lesions 1. This represents a significant shift enabling earlier intervention.
In real-world application, RIS reclassification accounted for 35% of additional diagnoses under the 2024 criteria 3.
CSF Kappa Free Light Chains
Kappa free light chains are now recognized as an alternative CSF biomarker alongside oligoclonal bands for supporting MS diagnosis 2, 4.
Recommended Imaging Strategy
Initial Diagnostic Workup
Brain AND whole spinal cord imaging should be performed at diagnosis 1:
- Gadolinium-based contrast administration is essential initially to detect enhancing lesions and establish DIT if both enhancing and non-enhancing lesions are present simultaneously
- Susceptibility-sensitive sequences should be included routinely to assess for CVS and PRL 1
- Fat-saturated sequences for optic nerve evaluation when optic neuritis is suspected 1
Follow-up Imaging
- Repeat brain MRI can be performed without gadolinium - new T2-FLAIR lesions alone suffice for demonstrating DIT 1
- Repeat spinal cord imaging is not routinely recommended - isolated new spinal cord lesions without brain lesions are rare 1
Technical Requirements
MRI field strength: 1.5T or 3T with maximum in-plane resolution of 1 × 1 mm 1
Core brain sequences 1:
- T2-FLAIR (preferably 3D) for lesion identification
- T2-weighted sequences for lesion confirmation
- Susceptibility-sensitive sequences for CVS/PRL assessment
- Post-contrast T1-weighted for enhancing lesions
3D acquisitions with isotropic voxels (≤1 mm) are preferred for optimal lesion detection and comparison with follow-up scans 1
Special Populations and Diagnostic Caution
Older Adults (≥50 years)
Stricter diagnostic thresholds apply to patients over age 50 to minimize misdiagnosis, given increased prevalence of vascular lesions and other mimics 2, 5. The criteria provide specific guidance for this population to maintain diagnostic specificity.
Patients with Comorbidities
Enhanced caution is required for patients with:
- Vascular risk factors
- Migraine or headache disorders
- These conditions increase risk of misdiagnosis due to overlapping imaging findings 2, 5
Pediatric Patients
Age-specific considerations apply to children to account for developmental differences and alternative diagnoses 2, 5.
Differential Diagnosis Considerations
Critical exclusion of alternative diagnoses remains paramount before applying the McDonald criteria 1. Key differentials requiring careful distinction:
- MOGAD (myelin oligodendrocyte glycoprotein antibody disease)
- AQP4+ NMOSD (aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder)
- Vascular disease
- Other inflammatory/infectious conditions
Real-World Performance Data
Diagnostic Sensitivity
The 2024 criteria demonstrated increased diagnostic sensitivity compared to 2017 criteria:
- 93.5% vs 84% in German cohort (p < 0.0001) 3
- 94.0% vs 90.2% in Chinese cohort (p = 0.023) 6
- 81.4% vs 74.9% in another validation study 7
Time to Diagnosis
Median time to diagnosis was reduced with the 2024 criteria, though not always reaching statistical significance 6, 7. Some patients achieved diagnosis 47 months earlier 6.
Sources of Additional Diagnoses
In the German cohort, additional diagnoses resulted from 3:
- Optic nerve involvement: 55%
- RIS reclassification: 35%
Role of CSF Analysis
CSF analysis remained essential in real-world application - 49% of patients required inflammatory CSF findings plus DIT in addition to MRI findings for diagnosis 3. This underscores that despite advances in imaging, CSF analysis continues to play a critical diagnostic role.
Implementation Challenges
Resource Limitations
Advanced imaging markers (CVS, PRL, optic nerve MRI) require specialized resources not universally available 4:
- Susceptibility-sensitive imaging capabilities
- Radiologist expertise and training
- Extended scanner time
Practical recommendation: Use a stratified diagnostic approach where CSF analysis remains essential, and advanced imaging markers are reserved for diagnostically uncertain cases 4.
Geographic Considerations
The criteria extend recommendations for use in diverse populations outside Europe and North America, recognizing global applicability while acknowledging resource variations 1.
Critical Pitfalls to Avoid
Do not skip spinal cord imaging at initial diagnosis - it's essential for comprehensive assessment and establishing baseline 1
Do not over-rely on advanced imaging markers when not available - conventional criteria components remain highly effective 6, 4
Do not diagnose MS without excluding alternative explanations - this remains the critical first step 1
Do not apply standard criteria uncritically to older adults - use enhanced caution and stricter thresholds 2, 5
Do not assume RIS automatically equals MS - specific conditions must be met and patient-centered therapeutic strategies are essential 4